SecBot SecBot
6-K ·Filed Jun 30, 2026

NCEL

NewcelX Ltd.
NEUTRAL
Impact 2/10
Horizonweeks Processed3mo ago SEC0001213900-26-073725
Notable filing: 6-K
Actionable Insight • Neutral

Routine Annual General Meeting outcome with all proposals passed — no material trading signal. Monitor for future operational or clinical developments, as the company's small market cap ($20M) could amplify any news-driven moves.

DirectionNeutral
Confidencehigh
Horizonweeks
Final: all horizons settled through T+60d ⚠ clustered
NCEL ▼ -23.47% at T+60d
NEUTRAL call -23.47% · α vs SPY -26.90% · entry $3.85 → $2.95
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
0.00%
call 0.00% · α +0.13%
$3.85
settled 4mo ago
T+5d
+4.16%
call +4.16% · α +3.89%
$4.01
settled 4mo ago
T+20d
-8.57%
call -8.57% · α -6.39%
$3.52
settled 3mo ago
T+60d
-23.47%
call -23.47% · α -26.90%
$2.95
settled 5w ago

Price Chart

Loading chart...

Executive Summary

NewcelX Ltd. filed a Form 6-K reporting that at its June 30, 2026 Annual General Shareholders' Meeting, all proposals were approved by the required majorities. The meeting's proposals had been previously described in a Notice and Invitation furnished as Exhibit 99.1 to the Company's June 5, 2026 Form 6-K. This filing is a routine procedural update confirming shareholder approval of ordinary-course governance items.

Key Facts

  • Annual General Shareholders' Meeting held on June 30, 2026
  • All proposals were approved by the required majorities
  • Proposals were described in the June 5, 2026 Form 6-K (Exhibit 99.1)
  • Filing is incorporated by reference into five Form F-3 registration statements

Financial Impact

No financial impact — routine meeting result with no material terms disclosed

Risk Factors

  • No material risks identified from this filing; company remains a clinical-stage biotech with inherent development and financing risks

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-073725
Document: 0001213900-26-073725-index-headers.html0001213900-26-073725
Document: 0001213900-26-073725-index.html0001213900-26-073725
Document: 0001213900-26-073725.txt0001213900-26-073725
17 reports for NCEL
Performance horizon
56% Hit rate @ T+5 5 of 9 directional calls Went positive at some point 5 of 9 best @ T+20▲ +95.57%Apr 1, 2026
Filters
Rows
Reports for NCEL, sortable and filterable
TypeNow
Sep 23, 2026
5w ago
EFFECT
BEARISH ★ 5/10
$2.86 $3.08▼ −7.52%▼ −8.19%$2.74 (+4.20%)
Sep 18, 2026
5w ago
6-K
BEARISH ★ 6/10
$2.97 $2.92▲ +1.68%▲ +0.66%$2.74 (+7.74%)
Aug 27, 2026
8w ago
EFFECT
BEARISH ★ 5/10
$3.42 $3.35▲ +2.05%▲ +1.28%$2.74 (+19.88%)
Jul 31, 2026
12w ago
6-K
MIXED ★ 5/10
$3.49 $3.31▼ −5.16%▼ −8.67%$2.74 (−21.49%)
Jul 15, 2026
14w ago
6-K
BULLISH ★ 5/10
$3.93 $3.65▼ −7.12%▼ −6.14%$2.74 (−30.28%)
Jul 8, 2026
15w ago
6-K
NEUTRAL ★ 3/10
$4.23 $3.98▼ −5.91%▼ −6.77%$2.74 (−35.22%)
Jul 1, 2026
16w ago
6-K
BULLISH ★ 7/10
$3.85 $4.01▲ +4.16%▲ +3.89%$2.74 (−28.83%)
Jun 30, 2026
17w ago
6-K
NEUTRAL ★ 2/10
$3.85 $4.01▲ +4.16%▲ +3.89%$2.74 (−28.83%)
Jun 18, 2026
18w ago
EFFECT
BEARISH ★ 5/10
$3.31 $3.55▼ −7.25%▼ −8.92%$2.74 (+17.22%)
Jun 5, 2026
20w ago
6-K
NEUTRAL ★ 4/10
$3.24 $3.20▼ −1.23%▼ −3.35%$2.74 (−15.43%)
Showing 10 of 17

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026